SGCB and pulmonary arterial hypertension: NO production is reduced owing to endothelial dysfunction in the pathological changes of heart failure, coronary artery disease, pulmonary hypertension, and hypertension; therefore, heme-dependent sGC activation and cGMP production are reduced.